Delivery Order SPE2DB22D1106-SPE2DB24FEYF9
Award Date
6/21/24
Potential Completion Date
6/24/24
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of 4,566,779,327 units of Fluticasone Propionate HFA 220 MCG 12GM, a pharmaceutical product. The contract, valued at $12,166.56, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, placed by the Defense Logistics Agency (DLA), a defense agency. This contract is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of Fluticasone Prop HFA 220 MCG 12GM pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, in the amount of $1,642.32. This is a firm fixed price delivery order contract with a completion date of June 14, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) held by...
This contract award is for the delivery of the pharmaceutical product Fluticasone Prop HFA 110 MCG 12GM to the Defense Logistics Agency (DLA). The award was made to the Amerisourcebergen Drug Corp, a major pharmaceutical distributor, through a Delivery Order under their existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range...
The U.S. Defense Logistics Agency (DLA) awarded a $19,013.88 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of 4,565,860,781 units of Fluticasone Prop HFA 220 MCG 12GM pharmaceutical products. This delivery order contract is part of a larger, up to $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,415,474 units of the pharmaceutical product Fluticasone Prop HFA 220 MCG 12GM. The contract has a firm fixed price of $1,542.47 and a period of performance ending on April 29, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA...
This federal contract award, valued at $1,116.21, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of fluticasone prop HFA 110 mcg 12gm, a pharmaceutical product, with a completion date of January 21, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 4,564,176,783 units of Fluticasone Propionate HFA 220 MCG 12GM. The contract has a ceiling value of $2,318.50 and a performance period through April 8, 2024. This award is issued under an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, valued up to $999,999,999.00 through December 31,...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of 4,563,647,510 units of Fluticasone Prop HFA 220 MCG 12GM, a pharmaceutical product, with a firm fixed price ceiling value of $3,222.03. The contract has an ultimate completion date of February 14, 2024. This award is associated with a larger Indefinite Delivery...
This contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,627,166 units of the pharmaceutical product FLUTICASONE PROP HFA 220 MCG 12GM. The $1,685.25 firm fixed price contract was issued by the Defense Logistics Agency (DLA), a defense agency, and has a May 17, 2024 completion date. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle to deliver a range of...
This federal contract award, valued at $2,407.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,061,625 units of Fluticasone Prop HFA 220 MCG 12GM, a pharmaceutical product, with a performance period ending on April 29, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition....